Literature DB >> 28687706

Bone Regulates Browning and Energy Metabolism Through Mature Osteoblast/Osteocyte PPARγ Expression.

Julia Brun1, Flavien Berthou2, Mirko Trajkovski2, Pierre Maechler2, Michanlegelo Foti2, Nicolas Bonnet3.   

Abstract

Peroxisome proliferator-activated receptor γ (PPARγ) is a master regulator of energy metabolism. In bone, it is known to regulate osteoblast differentiation and osteoclast activity. Whether PPARγ expression in bone cells, particularly osteocytes, regulates energy metabolism remains unknown. Here, we show that mature osteoblast/osteocyte-specific ablation of PPARγ in mice (Ocy-PPARγ-/-) alters body composition with age, namely, to produce less fat and more lean mass, and enhances insulin sensitivity and energy expenditure compared with wild-type mice. In addition, Ocy-PPARγ-/- mice exhibit more bone density, structure, and strength by uncoupling bone formation from resorption. When challenged with a high-fat diet, Ocy-PPARγ-/- mice retain glycemic control, with increased browning of the adipose tissue, decreased gluconeogenesis, and less hepatic steatosis. Moreover, these metabolic effects, particularly an increase in fatty acid oxidation, cannot be explained by decarboxylated osteocalcin changes, suggesting existence of other osteokines that are under the control of PPARγ. We further identify bone morphogenetic protein 7 as one of them. Hence, osteocytes coregulate bone and glucose homeostasis through a PPARγ regulatory pathway, and its inhibition could be clinically relevant for the prevention of glucose metabolic disorders.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28687706     DOI: 10.2337/db17-0116

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism.

Authors:  Soohyun P Kim; Hao Da; Zhu Li; Priyanka Kushwaha; Conor Beil; Lin Mei; Wen-Cheng Xiong; Michael J Wolfgang; Thomas L Clemens; Ryan C Riddle
Journal:  J Biol Chem       Date:  2019-03-06       Impact factor: 5.157

Review 2.  Energy Metabolism of Bone.

Authors:  Katherine J Motyl; Anyonya R Guntur; Adriana Lelis Carvalho; Clifford J Rosen
Journal:  Toxicol Pathol       Date:  2017-11-02       Impact factor: 1.902

Review 3.  Bone-Muscle Mutual Interactions.

Authors:  Nuria Lara-Castillo; Mark L Johnson
Journal:  Curr Osteoporos Rep       Date:  2020-08       Impact factor: 5.096

Review 4.  The osteocyte as a signaling cell.

Authors:  Jesus Delgado-Calle; Teresita Bellido
Journal:  Physiol Rev       Date:  2021-08-02       Impact factor: 37.312

Review 5.  Energy Metabolism of Osteocytes.

Authors:  Vivin Karthik; Anyonya R Guntur
Journal:  Curr Osteoporos Rep       Date:  2021-06-12       Impact factor: 5.096

6.  Osteocytes as main responders to low-intensity pulsed ultrasound treatment during fracture healing.

Authors:  Tatsuya Shimizu; Naomasa Fujita; Kiyomi Tsuji-Tamura; Yoshimasa Kitagawa; Toshiaki Fujisawa; Masato Tamura; Mari Sato
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

7.  Deletion of Rptor in Preosteoblasts Reveals a Role for the Mammalian Target of Rapamycin Complex 1 (mTORC1) Complex in Dietary-Induced Changes to Bone Mass and Glucose Homeostasis in Female Mice.

Authors:  Pawanrat Tangseefa; Sally K Martin; Agnieszka Arthur; Vasilios Panagopoulos; Amanda J Page; Gary A Wittert; Christopher G Proud; Stephen Fitter; Andrew C W Zannettino
Journal:  JBMR Plus       Date:  2021-03-24

8.  PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss.

Authors:  Sudipta Baroi; Piotr J Czernik; Amit Chougule; Patrick R Griffin; Beata Lecka-Czernik
Journal:  Bone       Date:  2021-03-16       Impact factor: 4.626

Review 9.  Osteon: Structure, Turnover, and Regeneration.

Authors:  Bei Chang; Xiaohua Liu
Journal:  Tissue Eng Part B Rev       Date:  2021-03-08       Impact factor: 7.376

10.  PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1ΔHBS in Chronic Kidney Diseases via Inhibition of TGF-β1/SMAD3 Signaling.

Authors:  Dezhong Wang; Tianyang Zhao; Yushuo Zhao; Yuan Yin; Yuli Huang; Zizhao Cheng; Beibei Wang; Sidan Liu; Minling Pan; Difei Sun; Zengshou Wang; Guanghui Zhu
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.